Selecting the optimal primary packaging for biologics: Practical application with PFS for Intravitreal Injections

Panel DiscussionThe Optimal Primary Packaging for Biologics: Practical Application with PFS for Intravitreal Injections

2025-06-05 | 11:15 AM - 11:30 AM | TPD Room

Information

Selecting the optimal primary packaging for biologics: Practical application with PFS for intravitreal injections

As biologic therapies for ocular diseases advance, selecting the right primary packaging—especially for intravitreal delivery—has become a critical factor in ensuring safety, stability, and performance. This panel discussion will explore key technical and regulatory considerations, recent innovations such as baked-on siliconization, and real-world insights from across the pharma and device landscape.

Moderated by Doris De Beer (TSK Laboratory Europe), the session brings together experts from Gerresheimer, Roche, and ten23 health for a focused exchange on how to optimize packaging strategies for injectable biologics in ophthalmology.

Speakers

GERRESHEIMER

Maximilian VOGL

GERRESHEIMER

Head of Product Management

GERRESHEIMER

Bernd ZEISS

GERRESHEIMER

Head of Scientific Affairs

ROCHE

Vincent CAZANAVE

ROCHE

Device Team Leader

TSK LABORATORY EUROPE

Doris DE BEER

TSK LABORATORY EUROPE

Managing Director

TEN23 HEALTH

Nicolas BRANDES

TEN23 HEALTH

Director Business Development & Sales